This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Dec 14;360(9349):1985.

doi: 10.1016/S0140-6736(02)11893-9.

Safety and usefulness of autologous cryopreserved platelets

Jean-Luc Wautier

PMID: 12493312
DOI: 10.1016/S0140-6736(02)11893-9

Comment

Safety and usefulness of autologous cryopreserved platelets

Jean-Luc Wautier. Lancet. 2002.

. 2002 Dec 14;360(9349):1985.

doi: 10.1016/S0140-6736(02)11893-9.

Author

Jean-Luc Wautier

PMID: 12493312
DOI: 10.1016/S0140-6736(02)11893-9

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S, Kavanagh JJ, Freedman RS, Folloder J, Currie LM, Bueso-Ramos C, Verschraegen CF, Narvios AB, Connor J, Hoots WK, Broemeling LD, Lichtiger B. Vadhan-Raj S, et al. Lancet. 2002 Jun 22;359(9324):2145-52. doi: 10.1016/S0140-6736(02)09090-6. Lancet. 2002. PMID: 12090979 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- ClinicalTrials.gov